Personis预计2025财年收入在6900万美元至7000万美元之间

2026-01-08 21:28

Personalis (PSNL) announced on Thursday that its total revenue is expected to be in the range of $69M to $70M, versus a consensus of $69.96M, compared with $84.6M for 2024.
The firm said its clinical test revenue reached approximately $2.0M, more than doubling the $0.8M reported in 2024.
The company added that pharma tests, services, and all other customers contributed approximately $49M to $50M. Revenue from enterprise sales (Natera) and population sequencing totaled approximately $18M.
For Q4, revenue is expected to be in the range of $17M to $18M vs. consensus of $17.55M.
The firm said it ended the year with approximately $240M in cash, cash equivalents, and short-term investments, including approximately $109M in net proceeds from its at-the-market sales program, executed at a weighted-average price of $8.43 per share.
PSNL -6.31% premarket to $8.76.
Source: Press Release

More on Personalis